Stephen V Liu, Associate Professor of Medicine at Georgetown University, Director of Thoracic Oncology and Head of Developmental Therapeutics at the Georgetown Lombardi Comprehensive Cancer Center, shared a post on X:
“Dr. Luis E. Raez with some updates on KRAS non-G12C at ITCD2025. G12D very relevant to lung and other cancers, can occur in those with no smoking history. Will G12D inhibitors emerge or pan KRAS or pan RAS? Expecting significant progress in the short term!”
